| __timestamp | Arrowhead Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 580006000 |
| Thursday, January 1, 2015 | 382000 | 676585000 |
| Friday, January 1, 2016 | 158333 | 778966000 |
| Sunday, January 1, 2017 | 31407709 | 671251000 |
| Monday, January 1, 2018 | 16142321 | 463508000 |
| Tuesday, January 1, 2019 | 168795577 | 445724000 |
| Wednesday, January 1, 2020 | 87992066 | 399725000 |
| Friday, January 1, 2021 | 138287000 | 296656000 |
| Saturday, January 1, 2022 | 232810000 | 293122000 |
| Sunday, January 1, 2023 | 240735000 | 268323000 |
| Monday, January 1, 2024 | 3551000 | 304979000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding financial health is crucial. This analysis compares the gross profit trajectories of Arrowhead Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. over a decade, from 2014 to 2024.
Arrowhead Pharmaceuticals, Inc. has shown a remarkable growth trajectory, with gross profits surging from a modest $175,000 in 2014 to an impressive $240 million by 2023. This represents a staggering increase of over 137,000%. However, 2024 shows a significant drop, indicating potential challenges ahead.
Conversely, Taro Pharmaceutical Industries Ltd. started strong with a gross profit of $580 million in 2014, peaking at $779 million in 2016. Since then, a steady decline has been observed, with profits falling to $268 million by 2023, a decrease of about 54% from its peak.
These trends highlight the dynamic nature of the pharmaceutical industry, where innovation and market conditions can dramatically impact financial outcomes.
Gross Profit Analysis: Comparing Novo Nordisk A/S and Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Amgen Inc. and Taro Pharmaceutical Industries Ltd.
Vertex Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Regeneron Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Genmab A/S and Arrowhead Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Catalent, Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends
Key Insights on Gross Profit: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Grifols, S.A. or Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. Trends
HUTCHMED (China) Limited vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown